Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.

Volume: 178, Issue: 5, Pages: 622 - 631
Published: May 1, 2018
Abstract
Importance null Quitting smoking is enhanced by the use of pharmacotherapies, but concerns have been raised regarding the cardiovascular safety of such medications. null Objective null To compare the relative cardiovascular safety risk of smoking cessation treatments. null Design, Setting, and Participants null A double-blind, randomized, triple-dummy, placebo- and active-controlled trial (Evaluating Adverse Events in a Global Smoking Cessation...
Paper Details
Title
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
Published Date
May 1, 2018
Volume
178
Issue
5
Pages
622 - 631
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.